<SEC-DOCUMENT>0000950170-24-064046.txt : 20240523
<SEC-HEADER>0000950170-24-064046.hdr.sgml : 20240523
<ACCEPTANCE-DATETIME>20240523172207
ACCESSION NUMBER:		0000950170-24-064046
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240523
DATE AS OF CHANGE:		20240523

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kymera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001815442
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				812992166
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39460
		FILM NUMBER:		24979729

	BUSINESS ADDRESS:	
		STREET 1:		500 NORTH BEACON STREET, 4TH FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		857-285-5314

	MAIL ADDRESS:	
		STREET 1:		500 NORTH BEACON STREET, 4TH FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chadwick Jeremy G
		CENTRAL INDEX KEY:			0001388406
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O KYMERA THERAPEUTICS, INC.
		STREET 2:		200 ARSENAL YARDS BLVD., SUITE 230
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001388406</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001815442</issuerCik>
<issuerName>KYMERA THERAPEUTICS, INC.</issuerName>
<secFileNumber>001-39460</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">500 NORTH BEACON STREET</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">4TH FLOOR</street2>
<city xmlns="http://www.sec.gov/edgar/common">WATERTOWN</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02472</zipCode>
</issuerAddress>
<issuerContactPhone>857-285-5300</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Chadwick Jeremy G </nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1 New York Plaza</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">38th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10004</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>2575</noOfUnitsSold>
<aggregateMarketValue>91928.00</aggregateMarketValue>
<noOfUnitsOutstanding>61358262</noOfUnitsOutstanding>
<approxSaleDate>05/23/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>05/22/2024</acquiredDate>
<natureOfAcquisitionTransaction>Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>KYMERA THERAPEUTICS, INC.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>2575</amountOfSecuritiesAcquired>
<paymentDate>05/22/2024</paymentDate>
<natureOfPayment>Equity compensation</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>The sales reported on this Form 144 represent shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales were automatic and intended to qualify under Rule 10b5-1.</remarks>
<noticeSignature>
<noticeDate>05/23/2024</noticeDate>
<signature>/s/ Jeremy Chadwick</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
